— Know what they know.
Not Investment Advice

TWST NASDAQ

Twist Bioscience Corporation
1W: +11.1% 1M: -6.9% 3M: +21.1% YTD: +81.7% 1Y: +90.4% 3Y: +355.8% 5Y: -36.5%
$60.57
+1.74 (+2.95%)
 
Weekly Expected Move ±8.2%
$41 $45 $49 $53 $57
NASDAQ · Healthcare · Medical - Diagnostics & Research · Alpha Radar Buy · Power 50 · $3.8B mcap · 60M float · 2.10% daily turnover · Short 54% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
53.5 / 100
NoneWeakNarrowWide
Primary source: Intangible Assets  ·  ROIC: -29.0%  ·  5Y Avg: -43.5%
Cost Advantage
45
Intangibles
69
Switching Cost
47
Network Effect
68
Scale
35
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. TWST shows a Weak competitive edge (53.5/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Intangible Assets. Negative ROIC of -29.0% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$60
Low
$68
Avg Target
$80
High
Based on 4 analysts since May 4, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 11Hold: 1Sell: 1Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$65.00
Analysts5
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-22 Leerink Partners Puneet Souda Initiated $80 +36.0% $58.84
2026-05-05 Guggenheim Subbu Nambi $50 $60 +10 +6.8% $56.19
2026-05-05 Robert W. Baird Catherine Ramsey Schulte $50 $65 +15 +15.7% $56.19
2026-05-04 Barclays $55 $65 +10 +15.7% $56.19
2026-04-14 Barclays Luke Sergott $50 $55 +5 +9.2% $50.38
2026-02-03 Robert W. Baird $44 $50 +6 +4.8% $47.73
2026-02-03 Evercore ISI $42 $52 +10 +9.7% $47.42
2026-02-03 Barclays $39 $50 +11 +6.8% $46.81
2026-01-05 Evercore ISI $46 $42 -4 +22.3% $34.35
2025-12-15 Barclays $40 $39 -1 +26.1% $30.94
2025-11-03 Stephens Steven Etoch Initiated $41 +29.9% $31.57
2025-10-02 Barclays $58 $40 -18 +36.7% $29.26
2025-08-04 Evercore ISI $36 $46 +10 +52.3% $30.21
2025-05-06 Robert W. Baird Catherine Ramsey Schulte $54 $44 -10 +34.4% $32.75
2025-03-28 Guggenheim $53 $50 -3 +23.9% $40.36
2025-02-04 Robert W. Baird Catherine Ramsey Schulte $46 $54 +8 +3.8% $52.02
2025-02-03 Barclays Luke Sergott $32 $58 +26 +10.0% $52.75
2024-09-17 Robert W. Baird Catherine Schulte $40 $46 +6 -4.5% $48.18
2024-06-05 Guggenheim Subbu Nambi Initiated $53 +12.8% $46.98
2024-05-03 Robert W. Baird Catherine Ramsey Schulte Initiated $40 +25.0% $32.01
2024-01-16 Goldman Sachs Matthew Sykes Initiated $45 +29.2% $34.84
2023-02-05 Barclays Luke Sergott $45 $32 -13 +26.4% $25.31
2023-01-03 Evercore ISI Initiated $36 +45.6% $24.73
2022-10-06 Barclays Luke Sergott Initiated $45 +16.9% $38.51

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C-
May 22, 2026
DCF
3
ROE
1
ROA
1
D/E
2
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. TWST receives an overall rating of C-. Areas of concern: ROE (1/5), ROA (1/5), D/E (2/5), P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-04-01 C C-
2026-02-02 C+ C
2026-01-03 C C+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

49 Grade D
Profitability
15
Balance Sheet
87
Earnings Quality
60
Growth
82
Value
33
Momentum
76
Safety
100
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. TWST scores highest in Safety (100/100) and lowest in Profitability (15/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
8.20
Safe Zone
Piotroski F-Score
5/9
Beneish M-Score
-1.99
Unlikely Manipulator
Ohlson O-Score
-7.53
Bankruptcy prob: 0.1%
Low Risk
Credit Rating
A
Score: 73.7/100
Trend: Improving
Earnings Quality
OCF/NI: 0.68x
Accruals: -4.1%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. TWST scores 8.20, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. TWST scores 5/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. TWST's score of -1.99 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. TWST's implied 0.1% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. TWST receives an estimated rating of A (score: 73.7/100), with a improving trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-45.98x
PEG
-0.67x
P/S
9.21x
P/B
8.21x
P/FCF
-30.82x
P/OCF
EV/EBITDA
-48.72x
EV/Revenue
6.93x
EV/EBIT
-34.42x
EV/FCF
-29.82x
Earnings Yield
-2.77%
FCF Yield
-3.24%
Shareholder Yield
0.00%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. TWST currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.009
NI / EBT
×
Interest Burden
0.977
EBT / EBIT
×
EBIT Margin
-0.201
EBIT / Rev
×
Asset Turnover
0.652
Rev / Assets
×
Equity Multiplier
1.328
Assets / Equity
=
ROE
-17.2%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. TWST's ROE of -17.2% is driven by Asset Turnover (0.652), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.01 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$60.57
Median 1Y
$52.16
5th Pctile
$15.41
95th Pctile
$175.72
Ann. Volatility
77.0%
Analyst Target
$65.00
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Emily M. Leproust,
Ph.D. Chief Executive Officer and Chair of the Board
$720,000 $11,998,134 $13,781,570
Patrick Finn, Ph.D.
President and Chief Operating Officer
$563,000 $6,748,947 $8,022,942
Adam Laponis Financial
ancial Officer
$490,000 $3,365,430 $4,216,117
Dennis Cho Legal
Legal Officer and Corporate Secretary
$449,000 $2,872,062 $3,621,076
Paula Green Human
r Vice President of Human Resources
$400,000 $2,570,537 $3,348,859

CEO Pay Ratio

55:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $13,781,570
Avg Employee Cost (SGA/emp): $252,274
Employees: 979

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
979
+6.1% YoY
Revenue / Employee
$384,650
Rev: $376,572,000
Profit / Employee
$-79,336
NI: $-77,670,000
SGA / Employee
$252,274
Avg labor cost proxy
R&D / Employee
$82,007
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE -55.4% -33.2% -35.9% -40.9% -45.4% -31.8% -31.3% -31.0% -30.6% -29.0% -29.1% -27.2% -31.2% -38.1% -36.0% -34.9% -15.5% -16.4% -16.2% -17.2% -17.19%
ROA -46.1% -27.6% -29.9% -34.1% -37.8% -26.2% -25.7% -25.6% -25.2% -23.5% -23.7% -22.1% -25.4% -30.0% -28.4% -27.5% -12.3% -12.4% -12.2% -12.9% -12.94%
ROIC -1.3% -72.7% -83.8% -94.6% -1.0% -48.9% -46.5% -46.7% -46.6% -45.0% -45.5% -42.9% -48.7% -62.0% -58.6% -56.5% -40.0% -28.5% -28.1% -29.0% -29.02%
ROCE -37.7% -24.0% -27.7% -31.3% -34.1% -26.2% -24.6% -24.3% -23.9% -28.9% -29.1% -27.2% -31.3% -38.3% -36.2% -35.1% -15.6% -13.9% -13.7% -15.0% -14.97%
Gross Margin 40.2% 40.7% 35.6% 38.3% 44.8% 44.9% 45.7% 30.8% 34.4% 36.6% 40.5% 41.0% 43.3% 45.1% 48.3% 49.6% 53.4% 51.3% 52.0% 51.6% 51.59%
Operating Margin -1.2% -1.0% -1.3% -1.3% -1.1% -99.2% -82.3% -1.0% -95.4% -74.9% -65.7% -64.9% -1.1% -42.5% -39.1% -44.8% -31.4% -30.2% -31.7% -41.4% -41.42%
Net Margin -1.1% -1.1% -1.1% -1.3% -1.1% -89.2% -77.1% -98.3% -90.0% -69.1% -60.2% -60.4% -1.1% -40.9% -35.6% -42.4% 21.2% -27.4% -29.4% -39.8% -39.76%
EBITDA Margin -1.1% -1.0% -1.3% -1.2% -1.0% -80.0% -67.2% -85.5% -75.7% -56.7% -48.6% -48.9% -94.6% -33.1% -28.3% -35.1% 27.5% -21.1% -23.2% -35.8% -35.83%
FCF Margin -97.7% -1.1% -1.2% -1.3% -1.4% -1.1% -1.1% -92.9% -70.0% -69.5% -49.1% -34.4% -25.4% -22.1% -20.7% -18.8% -19.0% -20.1% -22.1% -23.2% -23.23%
OCF Margin -80.9% -84.8% -91.6% -93.0% -85.7% -61.1% -61.1% -58.7% -52.3% -58.1% -42.5% -31.2% -23.5% -20.5% -18.9% -16.1% -14.1% -12.6% -13.0% -13.6% -13.58%
ROE 3Y Avg snapshot only -29.48%
ROE 5Y Avg snapshot only -29.53%
ROA 3Y Avg snapshot only -22.84%
ROIC 3Y Avg snapshot only -37.00%
ROIC Economic snapshot only -18.21%
Cash ROA snapshot only -8.66%
Cash ROIC snapshot only -14.71%
CROIC snapshot only -25.18%
NOPAT Margin snapshot only -26.78%
Pretax Margin snapshot only -19.67%
R&D / Revenue snapshot only 17.56%
SGA / Revenue snapshot only 66.66%
SBC / Revenue snapshot only 15.71%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio -48.27 -34.71 -23.44 -14.08 -9.46 -9.10 -6.28 -4.03 -5.57 -5.67 -10.30 -10.32 -13.01 -12.56 -13.93 -12.25 -26.42 -21.89 -25.30 -36.08 -45.983
P/S Ratio 51.45 39.89 26.42 16.19 10.68 9.74 6.23 3.76 4.96 4.73 8.08 7.14 9.71 8.38 8.33 6.74 6.21 4.52 4.95 7.16 9.211
P/B Ratio 19.40 9.09 6.65 4.55 3.39 2.51 1.70 1.08 1.48 1.86 3.40 3.18 4.60 5.55 5.82 4.95 4.76 3.60 4.10 6.20 8.212
P/FCF -52.68 -37.90 -22.70 -12.48 -7.83 -8.76 -5.78 -4.04 -7.08 -6.82 -16.45 -20.75 -38.23 -37.89 -40.20 -35.76 -32.75 -22.48 -22.34 -30.82 -30.819
P/OCF
EV/EBITDA -49.14 -33.79 -20.76 -11.86 -7.60 -7.43 -4.78 -2.35 -4.16 -5.27 -10.89 -11.03 -14.06 -13.75 -15.31 -13.21 -34.67 -30.75 -36.01 -48.72 -48.723
EV/Revenue 49.44 36.76 23.58 13.64 8.43 7.73 4.33 1.96 3.21 3.75 7.15 6.27 8.89 7.76 7.75 6.19 5.68 4.26 4.71 6.93 6.928
EV/EBIT -45.85 -31.65 -19.49 -11.13 -7.12 -6.89 -4.36 -2.11 -3.64 -4.51 -9.17 -9.10 -11.93 -11.67 -13.00 -11.28 -24.33 -20.91 -24.38 -34.42 -34.422
EV/FCF -50.63 -34.92 -20.26 -10.52 -6.18 -6.95 -4.01 -2.11 -4.59 -5.39 -14.57 -18.22 -35.00 -35.13 -37.40 -32.84 -29.96 -21.22 -21.24 -29.82 -29.819
Earnings Yield -2.1% -2.9% -4.3% -7.1% -10.6% -11.0% -15.9% -24.8% -18.0% -17.6% -9.7% -9.7% -7.7% -8.0% -7.2% -8.2% -3.8% -4.6% -4.0% -2.8% -2.77%
FCF Yield -1.9% -2.6% -4.4% -8.0% -12.8% -11.4% -17.3% -24.7% -14.1% -14.7% -6.1% -4.8% -2.6% -2.6% -2.5% -2.8% -3.1% -4.4% -4.5% -3.2% -3.24%
Price/Tangible Book snapshot only 7.770
EV/Gross Profit snapshot only 13.305
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 9.29 8.67 8.67 8.67 8.67 6.58 6.58 6.58 6.58 5.79 5.79 5.79 5.79 4.88 4.88 4.88 4.88 3.64 3.64 3.64 3.643
Quick Ratio 8.95 8.16 8.16 8.16 8.16 6.15 6.15 6.15 6.15 5.35 5.35 5.35 5.35 4.54 4.54 4.54 4.54 3.33 3.33 3.33 3.333
Debt/Equity 0.11 0.11 0.11 0.11 0.11 0.12 0.12 0.12 0.12 0.15 0.15 0.15 0.15 0.18 0.18 0.18 0.18 0.29 0.29 0.29 0.290
Net Debt/Equity -0.76 -0.71 -0.71 -0.71 -0.71 -0.52 -0.52 -0.52 -0.52 -0.39 -0.39 -0.39 -0.39 -0.40 -0.40 -0.40 -0.40 -0.20 -0.20 -0.20 -0.201
Debt/Assets 0.09 0.09 0.09 0.09 0.09 0.10 0.10 0.10 0.10 0.12 0.12 0.12 0.12 0.14 0.14 0.14 0.14 0.21 0.21 0.21 0.214
Debt/EBITDA -0.28 -0.44 -0.38 -0.34 -0.31 -0.45 -0.49 -0.50 -0.52 -0.54 -0.55 -0.60 -0.50 -0.48 -0.51 -0.52 -1.43 -2.63 -2.68 -2.36 -2.358
Net Debt/EBITDA 1.99 2.88 2.50 2.21 2.03 1.94 2.10 2.16 2.25 1.39 1.41 1.54 1.30 1.08 1.15 1.18 3.22 1.82 1.86 1.63 1.633
Interest Coverage -321.02 -419.84 -645.50 -961.02 -1581.26 -2817.20 -3821.39 -7299.59 -6926.47 -40692.20 -51150.50 -95635.50 -219879.00 -7177.17 -3711.75 -972.38 -431.76 -459.78 -528.43
Equity Multiplier 1.19 1.21 1.21 1.21 1.21 1.22 1.22 1.22 1.22 1.25 1.25 1.25 1.25 1.30 1.30 1.30 1.30 1.36 1.36 1.36 1.357
Cash Ratio snapshot only 2.543
Cash to Debt snapshot only 1.693
FCF to Debt snapshot only -0.693
Defensive Interval snapshot only 300.1 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.43 0.24 0.27 0.30 0.33 0.24 0.26 0.27 0.28 0.28 0.30 0.32 0.34 0.45 0.47 0.50 0.52 0.60 0.62 0.65 0.652
Inventory Turnover 7.72 3.66 4.06 4.55 5.00 3.36 3.42 3.76 4.07 4.35 4.72 4.80 4.92 6.40 6.52 6.60 6.55 7.08 7.23 7.49 7.492
Receivables Turnover 7.00 5.13 5.66 6.32 7.13 6.14 6.51 6.88 7.11 5.83 6.24 6.60 7.02 7.93 8.36 8.81 9.18 8.19 8.52 8.91 8.909
Payables Turnover 10.38 8.17 9.07 10.16 11.17 6.82 6.96 7.64 8.26 9.10 9.87 10.03 10.28 22.91 23.33 23.63 23.45 29.17 29.77 30.85 30.847
DSO 52 71 64 58 51 59 56 53 51 63 59 55 52 46 44 41 40 45 43 41 41.0 days
DIO 47 100 90 80 73 109 107 97 90 84 77 76 74 57 56 55 56 52 50 49 48.7 days
DPO 35 45 40 36 33 54 52 48 44 40 37 36 35 16 16 15 16 13 12 12 11.8 days
Cash Conversion Cycle 64 126 114 102 91 115 110 102 97 106 99 95 91 87 84 81 80 84 81 78 77.9 days
Fixed Asset Turnover snapshot only 2.700
Operating Cycle snapshot only 89.7 days
Cash Velocity snapshot only 1.762
Capital Intensity snapshot only 1.568
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 72.8% 46.9% 44.6% 44.3% 45.3% 53.8% 47.6% 39.7% 27.8% 20.4% 21.6% 21.8% 25.4% 27.7% 25.9% 25.3% 22.7% 20.3% 18.6% 17.8% 17.77%
Net Income 7.9% -8.7% -40.6% -52.0% -53.9% -43.2% -30.0% -13.4% -0.7% 6.1% 3.9% 9.6% -5.2% -2.0% 4.1% 0.5% 61.3% 62.8% 61.2% 57.5% 57.48%
EPS 21.3% 1.4% -29.6% -38.5% -33.8% -25.6% -14.9% -6.8% 0.6% 7.7% 5.6% 11.2% -3.2% -0.7% 6.8% 3.6% 63.2% 64.3% 62.4% 58.9% 58.89%
FCF 18.5% 8.4% -18.4% -83.5% -1.0% -62.4% -36.7% -0.1% 34.4% 24.7% 44.6% 54.9% 54.5% 59.4% 46.9% 31.4% 8.3% -9.3% -26.8% -45.3% -45.27%
EBITDA 8.4% -9.0% -52.5% -64.2% -60.0% -47.0% -17.6% -1.3% 10.9% 17.7% 11.7% 16.9% -2.5% -1.5% 3.1% -3.2% 68.2% 70.5% 69.4% 64.2% 64.24%
Op. Income 7.3% -9.0% -50.3% -61.6% -59.1% -53.7% -27.1% -12.9% -2.8% 7.5% 1.8% 7.8% -4.9% -1.7% 5.0% 2.7% 39.4% 38.3% 35.5% 31.0% 30.99%
OCF Growth snapshot only 0.94%
Asset Growth snapshot only 4.48%
Equity Growth snapshot only 0.06%
Debt Growth snapshot only 61.51%
Shares Change snapshot only 3.44%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y 1.3% 86.7% 68.3% 55.3% 53.2% 51.3% 47.5% 39.6% 37.4% 34.9% 32.5% 33.2% 31.2% 28.7% 25.3% 22.8% 22.0% 21.6% 21.58%
Revenue 5Y 86.9% 61.8% 50.2% 41.9% 40.6% 39.5% 37.6% 33.1% 31.1% 29.4% 29.37%
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y
EBITDA 5Y
Gross Profit 3Y 2.6% 1.7% 1.3% 1.1% 85.9% 74.2% 46.2% 38.5% 36.5% 32.8% 37.1% 37.5% 37.2% 34.1% 31.4% 29.0% 31.3% 31.31%
Gross Profit 5Y 1.4% 1.0% 80.5% 68.9% 61.8% 59.7% 46.1% 41.7% 38.6% 38.55%
Op. Income 3Y
Op. Income 5Y
FCF 3Y
FCF 5Y
OCF 3Y
OCF 5Y
Assets 3Y 82.4% 82.4% 82.4% 72.6% 72.6% 72.6% 72.6% 24.9% 24.9% 24.9% 24.9% -4.4% -4.4% -4.4% -4.4% -12.6% -12.6% -12.6% -12.60%
Assets 5Y 46.3% 46.3% 46.3% 26.9% 26.9% 26.9% 26.9% 10.0% 10.0% 10.0% 9.98%
Equity 3Y 73.1% 73.1% 73.1% 73.1% 22.8% 22.8% 22.8% 22.8% -6.6% -6.6% -6.6% -6.6% -15.7% -15.7% -15.7% -15.70%
Book Value 3Y 44.3% 44.7% 50.3% 56.1% 13.2% 14.0% 16.1% 16.0% -11.5% -11.8% -10.0% -9.2% -17.7% -17.9% -18.0% -18.00%
Dividend 3Y
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.99 1.00 1.00 1.00 0.99 0.97 0.98 0.99 1.00 0.99 0.99 0.99 1.00 0.99 0.99 1.00 1.00 1.00 1.00 1.00 0.998
Earnings Stability 0.61 0.94 0.70 0.76 0.84 0.91 0.83 0.84 0.86 0.88 0.81 0.76 0.86 0.83 0.67 0.53 0.00 0.02 0.01 0.05 0.053
Margin Stability 0.36 0.51 0.13 0.41 0.47 0.59 0.67 0.75 0.77 0.89 0.37 0.54 0.59 0.64 0.70 0.76 0.76 0.83 0.84 0.85 0.854
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.00 0.00 1.00 1.00 0.50 0.50 1.00 1.00 1.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.97 0.97 0.84 0.50 0.50 0.83 0.88 0.95 1.00 0.98 0.98 0.96 0.98 0.99 0.98 1.00 0.50 0.50 0.50 0.50 0.500
Earnings Smoothness
ROE Trend 0.30 0.35 0.34 0.33 0.06 0.04 0.08 0.11 -0.06 -0.05 -0.01 -0.04 -0.14 -0.12 -0.12 0.13 0.22 0.21 0.18 0.184
Gross Margin Trend 0.24 0.17 0.12 0.09 0.08 0.06 0.07 0.04 -0.02 -0.04 -0.05 -0.02 0.01 0.04 0.05 0.07 0.10 0.11 0.11 0.10 0.096
FCF Margin Trend 1.03 0.74 0.51 0.37 0.16 0.26 0.21 0.23 0.47 0.39 0.63 0.77 0.78 0.68 0.58 0.45 0.29 0.26 0.13 0.03 0.034
Sustainable Growth Rate
Internal Growth Rate
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 0.76 0.74 0.81 0.81 0.76 0.57 0.62 0.63 0.59 0.70 0.54 0.45 0.32 0.31 0.32 0.29 0.60 0.61 0.67 0.68 0.684
FCF/OCF 1.21 1.24 1.27 1.39 1.59 1.82 1.77 1.58 1.34 1.19 1.16 1.10 1.08 1.08 1.09 1.17 1.34 1.59 1.70 1.71 1.712
FCF/Net Income snapshot only 1.171
CapEx/Revenue 16.7% 20.4% 24.8% 36.7% 50.7% 50.0% 46.8% 34.2% 17.8% 11.3% 6.7% 3.2% 1.9% 1.6% 1.8% 2.7% 4.9% 7.4% 9.1% 9.7% 9.66%
CapEx/Depreciation snapshot only 1.635
Accruals Ratio -0.11 -0.07 -0.06 -0.06 -0.09 -0.11 -0.10 -0.09 -0.10 -0.07 -0.11 -0.12 -0.17 -0.21 -0.19 -0.19 -0.05 -0.05 -0.04 -0.04 -0.041
Sloan Accruals snapshot only -0.093
Cash Flow Adequacy snapshot only -1.405
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio
FCF Payout Ratio
Total Payout Ratio
Div. Increase Streak
Chowder Number
Buyback Yield 0.1% 0.2% 0.3% 0.3% 0.4% 0.4% 0.5% 0.7% 0.4% 0.4% 0.3% 0.3% 0.2% 0.2% 0.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -4.8% -5.9% 0.3% -9.9% -13.3% -13.2% -19.6% 0.7% 0.4% 0.4% 0.3% 0.3% 0.2% 0.2% 0.1% 0.0% -0.1% -0.1% -0.1% -0.2% -0.21%
Total Shareholder Return -4.8% -5.9% 0.3% -9.9% -13.3% -13.2% -19.6% 0.7% 0.4% 0.4% 0.3% 0.3% 0.2% 0.2% 0.1% 0.0% -0.1% -0.1% -0.1% -0.2% -0.21%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 0.99 0.99 0.93 0.94 0.95 0.95 1.00 1.00 1.01 1.01 1.01 1.00 1.00 1.00 1.00 1.00 1.01 1.01 1.01 1.01 1.009
Interest Burden (EBT/EBIT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.98 0.977
EBIT Margin -1.08 -1.16 -1.21 -1.23 -1.18 -1.12 -0.99 -0.93 -0.88 -0.83 -0.78 -0.69 -0.74 -0.67 -0.60 -0.55 -0.23 -0.20 -0.19 -0.20 -0.201
Asset Turnover 0.43 0.24 0.27 0.30 0.33 0.24 0.26 0.27 0.28 0.28 0.30 0.32 0.34 0.45 0.47 0.50 0.52 0.60 0.62 0.65 0.652
Equity Multiplier 1.20 1.20 1.20 1.20 1.20 1.21 1.21 1.21 1.21 1.23 1.23 1.23 1.23 1.27 1.27 1.27 1.27 1.33 1.33 1.33 1.328
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $-2.76 $-3.08 $-3.30 $-3.51 $-3.70 $-3.87 $-3.79 $-3.74 $-3.67 $-3.57 $-3.58 $-3.33 $-3.79 $-3.60 $-3.34 $-3.20 $-1.39 $-1.29 $-1.25 $-1.32 $-1.32
Book Value/Share $6.87 $11.77 $11.64 $10.86 $10.32 $14.03 $13.99 $13.90 $13.84 $10.88 $10.84 $10.79 $10.72 $8.15 $7.99 $7.92 $7.73 $7.83 $7.74 $7.67 $7.38
Tangible Book/Share $6.84 $10.94 $10.82 $10.10 $9.60 $11.44 $11.41 $11.34 $11.29 $8.43 $8.40 $8.36 $8.31 $6.42 $6.29 $6.24 $6.09 $6.24 $6.18 $6.12 $6.12
Revenue/Share $2.59 $2.68 $2.93 $3.05 $3.27 $3.62 $3.82 $4.01 $4.13 $4.28 $4.56 $4.80 $5.08 $5.39 $5.58 $5.83 $5.92 $6.23 $6.41 $6.64 $6.64
FCF/Share $-2.53 $-2.82 $-3.41 $-3.96 $-4.47 $-4.02 $-4.12 $-3.73 $-2.89 $-2.97 $-2.24 $-1.65 $-1.29 $-1.19 $-1.16 $-1.10 $-1.12 $-1.25 $-1.42 $-1.54 $-1.54
OCF/Share $-2.10 $-2.27 $-2.68 $-2.84 $-2.81 $-2.21 $-2.34 $-2.36 $-2.16 $-2.49 $-1.94 $-1.50 $-1.19 $-1.10 $-1.06 $-0.94 $-0.84 $-0.79 $-0.84 $-0.90 $-0.90
Cash/Share $5.92 $9.68 $9.57 $8.94 $8.49 $8.97 $8.95 $8.89 $8.85 $5.87 $5.85 $5.82 $5.79 $4.76 $4.67 $4.63 $4.52 $3.85 $3.81 $3.77 $2.78
EBITDA/Share $-2.61 $-2.92 $-3.33 $-3.51 $-3.63 $-3.76 $-3.46 $-3.35 $-3.19 $-3.04 $-3.00 $-2.73 $-3.21 $-3.05 $-2.82 $-2.73 $-0.97 $-0.86 $-0.84 $-0.94 $-0.94
Debt/Share $0.73 $1.27 $1.26 $1.18 $1.12 $1.69 $1.68 $1.67 $1.66 $1.64 $1.64 $1.63 $1.62 $1.47 $1.44 $1.43 $1.39 $2.27 $2.25 $2.23 $2.23
Net Debt/Share $-5.19 $-8.41 $-8.31 $-7.76 $-7.37 $-7.29 $-7.26 $-7.22 $-7.19 $-4.23 $-4.21 $-4.19 $-4.17 $-3.30 $-3.23 $-3.21 $-3.13 $-1.57 $-1.56 $-1.54 $-1.54
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score 8.203
Altman Z-Prime snapshot only 13.131
Piotroski F-Score 6 4 4 3 4 4 4 4 4 2 2 4 3 3 3 3 4 5 5 5 5
Beneish M-Score -2.33 -0.50 -0.41 -0.38 -0.50 -2.00 -2.02 -1.78 -1.78 -2.59 -2.83 -3.10 -3.36 -3.89 -3.81 -3.84 -3.10 -2.07 -2.02 -1.99 -1.993
Ohlson O-Score snapshot only -7.527
ROIC (Greenblatt) snapshot only -20.96%
Net-Net WC snapshot only $2.66
EVA snapshot only $-147450820.00
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only A
Credit Score 59.98 60.18 59.21 60.44 60.73 61.72 59.76 47.98 56.43 52.75 63.35 63.78 63.71 63.90 63.55 63.56 63.76 59.32 63.03 73.68 73.685
Credit Grade snapshot only 6
Credit Trend snapshot only 10.125
Implied Spread (bps) snapshot only 150.000
Industry Credit Rank snapshot only 70
Sector Credit Rank snapshot only 69

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms